Rugvænget 5
Ansager 6823
Denmark
45 69 16 03 93
https://www.dancann.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Jeppe Krog Rasmussen | Founder, Member of Executive Board, Director & CEO | N/A | N/A | 1995 |
Mr. Peter Hauberg Sondergaard | Chief Financial Officer | N/A | N/A | 1972 |
Mr. Jens Markussen | Head of Production | N/A | N/A | N/A |
Mr. John Morell Frellsen | Chief Commercial Officer | N/A | N/A | N/A |
Ms. Charlotte Hagedorn Jorgensen | Head of Quality Assurance | N/A | N/A | N/A |
Dancann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in various disease areas. The company produces and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. Dancann Pharma A/S was incorporated in 2018 and is based in Ansager, Denmark.
Dancann Pharma A/Ss ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.